-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Enlivex Therapeutics Ltd. quarterly/annual General and Administrative Expense history and growth rate from Q2 2019 to Q2 2024.
- Enlivex Therapeutics Ltd. General and Administrative Expense for the quarter ending June 30, 2024 was $987K, a 38.8% decline year-over-year.
- Enlivex Therapeutics Ltd. annual General and Administrative Expense for 2023 was $6.14M, a 13.6% decline from 2022.
- Enlivex Therapeutics Ltd. annual General and Administrative Expense for 2022 was $7.1M, a 10.9% increase from 2021.
- Enlivex Therapeutics Ltd. annual General and Administrative Expense for 2021 was $6.41M, a 73.2% increase from 2020.
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)